Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating DR-2041 (Synthetic Conjugated Estrogens, A) for treatment of vulvovaginal atrophy in menopause completed; results were posted in 2009…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Vulvovaginal Atrophy

Drugs mentioned

• DR-2041 (Synthetic Conjugated Estrogens, A)

Snippet

Sponsor: Duramed Research | Conditions: Menopause | Phase 3 | Status: COMPLETED | Results posted: 2009-04-14